Investing Profile

Sara Secall

InvestorVC
Partner at INVEREADY ASSET MANAGEMENT SGEIC SA
inveready.com/team/Barcelona, Spain
Photo of Sara Secall, Partner at INVEREADY ASSET MANAGEMENT SGEIC SA

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Hotmail Network
4899 CONNECTIONS
Hotmail Network
4899 CONNECTIONS
London Business School Network
137 CONNECTIONS
Indiana University Bloomington Network
60 CONNECTIONS
European Commission Network
34 CONNECTIONS
cb
$300K - $1.8M
$875K
7
CompanyStageDateRound SizeTotal Raised
Iteria Biopharma
SeedApr 2026$6M
$6M
Ability Pharmaceuticals
Series UnknownMar 2024$8M
$8M
Innerva Pharmaceuticals
SeedOct 2022$2M
$2M
AptaTargets
Series BOct 2020$6M
Series UnknownMay 2017$3M
$9M
Qrem
SeedMar 2020$1M
$1M
Spiral Therapeutics
Series ADec 2018$6M
$6M
Co-investors: George C. Petrocheilos (Catalio Capital Management)
Consultant URS Corporation, An AECOM CompanyPresent
Consultant The World BankPresent
Sr. Analyst ChevronPresent
Director-Technology Based Start Ups HotmailPresent
Expert-H2020 projects European CommissionPresent
Director Inveready Biotech II InvereadyPresent
Board Member HotmailPresent
Board Member AGRASYSPresent
Board Member ZIP Solutions, S.L.Present
Board Member OncostellaePresent
Board Member AptaTargetsPresent
Board Member 53BiologicsPresent
Board Observer Edesa Biotech, Inc.Present
Board Member AbilityPharmaPresent
Board Member OXOLIFEPresent
Board Member CONNECTA TherapeuticsPresent
Board Member AmacaTheraPresent
Partner INVEREADY ASSET MANAGEMENT SGEIC SAPresent
Indiana University Bloomington Master in Sciences Environmental Science
London Business School MBA Venture Capital, Start Ups, Finance